APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Heart Lung Machines

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Selected research

Industry Research

Artificial Heart Lung Machines Industry Research Report 2026

1 January 2026124 pages

Choose your research edition.

Industry ResearchArtificial Heart Lung Machines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Heart Lung Machines Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artificial Heart Lung Machines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Heart Lung Machines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Heart Lung Machines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.

Report Scope

Read the full market overview

This report quantifies the global Artificial Heart Lung Machines market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Artificial Heart Lung Machines Market by Company

LivaNova (Sorin)

Getinge (Maquet)

Medtronic

Terumo CV Group

Braile Biomedica

Tianjin Medical

Artificial Heart Lung Machines Segment by Type

Single Roller Pump HLM

Double Roller Pump HLM

Artificial Heart Lung Machines Segment by Application

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Artificial Heart Lung Machines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Heart Lung Machines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Heart Lung Machines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Heart Lung Machines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Artificial Heart Lung Machines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Artificial Heart Lung Machines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Artificial Heart Lung Machines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Artificial Heart Lung Machines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Artificial Heart Lung Machines Sales (Units) of Manufacturers (2021-2026) Table 7. Global Artificial Heart Lung Machines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Artificial Heart Lung Machines Revenue of Manufacturers (2021-2026) Table 9. Global Artificial Heart Lung Machines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Artificial Heart Lung Machines Average Price (K USD/Unit) of Manufacturers (2021-2026) Table 11. Global Artificial Heart Lung Machines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Artificial Heart Lung Machines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Artificial Heart Lung Machines, Product Type & Application Table 14. Global Artificial Heart Lung Machines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Artificial Heart Lung Machines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. LivaNova (Sorin) Company Information Table 19. LivaNova (Sorin) Business Overview Table 20. LivaNova (Sorin) Artificial Heart Lung Machines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 21. LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio Table 22. LivaNova (Sorin) Recent Developments Table 23. Getinge (Maquet) Company Information Table 24. Getinge (Maquet) Business Overview Table 25. Getinge (Maquet) Artificial Heart Lung Machines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 26. Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio Table 27. Getinge (Maquet) Recent Developments Table 28. Medtronic Company Information Table 29. Medtronic Business Overview Table 30. Medtronic Artificial Heart Lung Machines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 31. Medtronic Artificial Heart Lung Machines Product Portfolio Table 32. Medtronic Recent Developments Table 33. Terumo CV Group Company Information Table 34. Terumo CV Group Business Overview Table 35. Terumo CV Group Artificial Heart Lung Machines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 36. Terumo CV Group Artificial Heart Lung Machines Product Portfolio Table 37. Terumo CV Group Recent Developments Table 38. Braile Biomedica Company Information Table 39. Braile Biomedica Business Overview Table 40. Braile Biomedica Artificial Heart Lung Machines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 41. Braile Biomedica Artificial Heart Lung Machines Product Portfolio Table 42. Braile Biomedica Recent Developments Table 43. Tianjin Medical Company Information Table 44. Tianjin Medical Business Overview Table 45. Tianjin Medical Artificial Heart Lung Machines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 46. Tianjin Medical Artificial Heart Lung Machines Product Portfolio Table 47. Tianjin Medical Recent Developments Table 48. Global Artificial Heart Lung Machines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 49. Global Artificial Heart Lung Machines Sales by Region (2021-2026) & (Units) Table 50. Global Artificial Heart Lung Machines Sales Market Share by Region (2021-2026) Table 51. Global Artificial Heart Lung Machines Sales by Region (2027-2032) & (Units) Table 52. Global Artificial Heart Lung Machines Sales Market Share by Region (2027-2032) Table 53. Global Artificial Heart Lung Machines Revenue by Region (2021-2026) & (US$ Million) Table 54. Global Artificial Heart Lung Machines Revenue Market Share by Region (2021-2026) Table 55. Global Artificial Heart Lung Machines Revenue by Region (2027-2032) & (US$ Million) Table 56. Global Artificial Heart Lung Machines Revenue Market Share by Region (2027-2032) Table 57. North America Artificial Heart Lung Machines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. North America Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 59. North America Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 60. North America Artificial Heart Lung Machines Revenue by Country (2021-2026) & (US$ Million) Table 61. North America Artificial Heart Lung Machines Revenue by Country (2027-2032) & (US$ Million) Table 62. Europe Artificial Heart Lung Machines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Europe Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 64. Europe Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 65. Europe Artificial Heart Lung Machines Revenue by Country (2021-2026) & (US$ Million) Table 66. Europe Artificial Heart Lung Machines Revenue by Country (2027-2032) & (US$ Million) Table 67. Asia Pacific Artificial Heart Lung Machines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Asia Pacific Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 69. Asia Pacific Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 70. Asia Pacific Artificial Heart Lung Machines Revenue by Country (2021-2026) & (US$ Million) Table 71. Asia Pacific Artificial Heart Lung Machines Revenue by Country (2027-2032) & (US$ Million) Table 72. South America Artificial Heart Lung Machines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. South America Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 74. South America Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 75. South America Artificial Heart Lung Machines Revenue by Country (2021-2026) & (US$ Million) Table 76. South America Artificial Heart Lung Machines Revenue by Country (2027-2032) & (US$ Million) Table 77. Middle East and Africa Artificial Heart Lung Machines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Middle East and Africa Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units) Table 79. Middle East and Africa Artificial Heart Lung Machines Sales by Country (2027-2032) & (Units) Table 80. Middle East and Africa Artificial Heart Lung Machines Revenue by Country (2021-2026) & (US$ Million) Table 81. Middle East and Africa Artificial Heart Lung Machines Revenue by Country (2027-2032) & (US$ Million) Table 82. Global Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units) Table 83. Global Artificial Heart Lung Machines Sales by Type (2027-2032) & (Units) Table 84. Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2026) Table 85. Global Artificial Heart Lung Machines Sales Market Share by Type (2027-2032) Table 86. Global Artificial Heart Lung Machines Revenue by Type (2021-2026) & (US$ Million) Table 87. Global Artificial Heart Lung Machines Revenue by Type (2027-2032) & (US$ Million) Table 88. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2026) Table 89. Global Artificial Heart Lung Machines Revenue Market Share by Type (2027-2032) Table 90. Global Artificial Heart Lung Machines Price by Type (2021-2026) & (K USD/Unit) Table 91. Global Artificial Heart Lung Machines Price by Type (2027-2032) & (K USD/Unit) Table 92. Global Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units) Table 93. Global Artificial Heart Lung Machines Sales by Application (2027-2032) & (Units) Table 94. Global Artificial Heart Lung Machines Sales Market Share by Application (2021-2026) Table 95. Global Artificial Heart Lung Machines Sales Market Share by Application (2027-2032) Table 96. Global Artificial Heart Lung Machines Revenue by Application (2021-2026) & (US$ Million) Table 97. Global Artificial Heart Lung Machines Revenue by Application (2027-2032) & (US$ Million) Table 98. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2026) Table 99. Global Artificial Heart Lung Machines Revenue Market Share by Application (2027-2032) Table 100. Global Artificial Heart Lung Machines Price by Application (2021-2026) & (K USD/Unit) Table 101. Global Artificial Heart Lung Machines Price by Application (2027-2032) & (K USD/Unit) Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Artificial Heart Lung Machines Distributors List Table 105. Artificial Heart Lung Machines Customers List Table 106. Artificial Heart Lung Machines Industry Trends Table 107. Artificial Heart Lung Machines Industry Drivers Table 108. Artificial Heart Lung Machines Industry Restraints Table 109. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Artificial Heart Lung Machines Product Image Figure 5. Global Artificial Heart Lung Machines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Artificial Heart Lung Machines Market Size (2021-2032) & (US$ Million) Figure 7. Global Artificial Heart Lung Machines Sales (2021-2032) & (Units) Figure 8. Global Artificial Heart Lung Machines Average Price (K USD/Unit) & (2021-2032) Figure 9. Single Roller Pump HLM Product Image Figure 10. Double Roller Pump HLM Product Image Figure 11. Cardiac Surgery Product Image Figure 12. Lung Transplant Operation Product Image Figure 13. Acute Respiratory Failure Treatment Product Image Figure 14. Others Product Image Figure 15. Global Artificial Heart Lung Machines Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Artificial Heart Lung Machines, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Artificial Heart Lung Machines Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Artificial Heart Lung Machines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Artificial Heart Lung Machines Sales by Region in 2025 Figure 21. Global Artificial Heart Lung Machines Revenue by Region in 2025 Figure 22. North America Artificial Heart Lung Machines Market Size by Country in 2025 Figure 23. North America Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 24. North America Artificial Heart Lung Machines Revenue Market Share by Country (2021-2032) Figure 25. United States Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Artificial Heart Lung Machines Market Size by Country in 2025 Figure 29. Europe Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 30. Europe Artificial Heart Lung Machines Revenue Market Share by Country (2021-2032) Figure 31. Germany Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Artificial Heart Lung Machines Market Size by Country in 2025 Figure 42. Asia Pacific Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Artificial Heart Lung Machines Revenue Market Share by Country (2021-2032) Figure 44. China Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Artificial Heart Lung Machines Market Size by Country in 2025 Figure 53. South America Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 54. South America Artificial Heart Lung Machines Revenue Market Share by Country (2021-2032) Figure 55. Brazil Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Artificial Heart Lung Machines Market Size by Country in 2025 Figure 60. Middle East and Africa Artificial Heart Lung Machines Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Artificial Heart Lung Machines Revenue Market Share by Country (2021-2032) Figure 62. Egypt Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Artificial Heart Lung Machines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2032) Figure 68. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2032) Figure 69. Global Artificial Heart Lung Machines Price (K USD/Unit) by Type (2021-2032) Figure 70. Global Artificial Heart Lung Machines Sales Market Share by Application (2021-2032) Figure 71. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2032) Figure 72. Global Artificial Heart Lung Machines Price (K USD/Unit) by Application (2021-2032) Figure 73. Artificial Heart Lung Machines Value Chain Figure 74. Artificial Heart Lung Machines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Artificial Heart Lung Machines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Single Roller Pump HLM
  • Double Roller Pump HLM
Applications
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Companies covered
  • LivaNova (Sorin)
  • Getinge (Maquet)
  • Medtronic
  • Terumo CV Group
  • Braile Biomedica
  • Tianjin Medical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Artificial Heart Lung Machines Market Size (2021-2032)
  4. 2.2.2 Global Artificial Heart Lung Machines Sales (2021-2032)
  5. 2.2.3 Global Artificial Heart Lung Machines Market Average Price (2021-2032)
  6. 2.3 Artificial Heart Lung Machines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Single Roller Pump HLM
  9. 2.3.3 Double Roller Pump HLM
  10. 2.4 Artificial Heart Lung Machines by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Cardiac Surgery
  13. 2.4.3 Lung Transplant Operation
  14. 2.4.4 Acute Respiratory Failure Treatment
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Artificial Heart Lung Machines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Artificial Heart Lung Machines Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Artificial Heart Lung Machines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Artificial Heart Lung Machines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Artificial Heart Lung Machines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Artificial Heart Lung Machines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Artificial Heart Lung Machines, Product Type & Application
  8. 3.8 Global Manufacturers of Artificial Heart Lung Machines, Established Date
  9. 3.9 Global Artificial Heart Lung Machines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 LivaNova (Sorin)
  2. 4.1.1 LivaNova (Sorin) Company Information
  3. 4.1.2 LivaNova (Sorin) Business Overview
  4. 4.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
  6. 4.1.5 LivaNova (Sorin) Recent Developments
  7. 4.2 Getinge (Maquet)
  8. 4.2.1 Getinge (Maquet) Company Information
  9. 4.2.2 Getinge (Maquet) Business Overview
  10. 4.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
  12. 4.2.5 Getinge (Maquet) Recent Developments
  13. 4.3 Medtronic
  14. 4.3.1 Medtronic Company Information
  15. 4.3.2 Medtronic Business Overview
  16. 4.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
  18. 4.3.5 Medtronic Recent Developments
  19. 4.4 Terumo CV Group
  20. 4.4.1 Terumo CV Group Company Information
  21. 4.4.2 Terumo CV Group Business Overview
  22. 4.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
  24. 4.4.5 Terumo CV Group Recent Developments
  25. 4.5 Braile Biomedica
  26. 4.5.1 Braile Biomedica Company Information
  27. 4.5.2 Braile Biomedica Business Overview
  28. 4.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
  30. 4.5.5 Braile Biomedica Recent Developments
  31. 4.6 Tianjin Medical
  32. 4.6.1 Tianjin Medical Company Information
  33. 4.6.2 Tianjin Medical Business Overview
  34. 4.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
  36. 4.6.5 Tianjin Medical Recent Developments
5 Global Artificial Heart Lung Machines Market Scenario by Region
  1. 5.1 Global Artificial Heart Lung Machines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Artificial Heart Lung Machines Sales by Region: 2021-2032
  3. 5.2.1 Global Artificial Heart Lung Machines Sales by Region: 2021-2026
  4. 5.2.2 Global Artificial Heart Lung Machines Sales by Region: 2027-2032
  5. 5.3 Global Artificial Heart Lung Machines Revenue by Region: 2021-2032
  6. 5.3.1 Global Artificial Heart Lung Machines Revenue by Region: 2021-2026
  7. 5.3.2 Global Artificial Heart Lung Machines Revenue by Region: 2027-2032
  8. 5.4 North America Artificial Heart Lung Machines Market Facts & Figures by Country
  9. 5.4.1 North America Artificial Heart Lung Machines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Artificial Heart Lung Machines Sales by Country (2021-2032)
  11. 5.4.3 North America Artificial Heart Lung Machines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Artificial Heart Lung Machines Market Facts & Figures by Country
  16. 5.5.1 Europe Artificial Heart Lung Machines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Artificial Heart Lung Machines Sales by Country (2021-2032)
  18. 5.5.3 Europe Artificial Heart Lung Machines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Artificial Heart Lung Machines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Artificial Heart Lung Machines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Artificial Heart Lung Machines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Artificial Heart Lung Machines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Artificial Heart Lung Machines Market Facts & Figures by Country
  41. 5.7.1 South America Artificial Heart Lung Machines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Artificial Heart Lung Machines Sales by Country (2021-2032)
  43. 5.7.3 South America Artificial Heart Lung Machines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Artificial Heart Lung Machines Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Artificial Heart Lung Machines Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Artificial Heart Lung Machines Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Artificial Heart Lung Machines Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Artificial Heart Lung Machines Sales by Type (2021-2032)
  2. 6.1.1 Global Artificial Heart Lung Machines Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Artificial Heart Lung Machines Revenue by Type (2021-2032)
  5. 6.2.1 Global Artificial Heart Lung Machines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Artificial Heart Lung Machines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Artificial Heart Lung Machines Sales by Application (2021-2032)
  2. 7.1.1 Global Artificial Heart Lung Machines Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Artificial Heart Lung Machines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Artificial Heart Lung Machines Revenue by Application (2021-2032)
  5. 7.2.1 Global Artificial Heart Lung Machines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Artificial Heart Lung Machines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Artificial Heart Lung Machines Value Chain Analysis
  2. 8.1.1 Artificial Heart Lung Machines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Artificial Heart Lung Machines Production Mode & Process
  5. 8.2 Artificial Heart Lung Machines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Artificial Heart Lung Machines Distributors
  8. 8.2.3 Artificial Heart Lung Machines Customers
9 Global Artificial Heart Lung Machines Analyzing Market Dynamics
  1. 9.1 Artificial Heart Lung Machines Industry Trends
  2. 9.2 Artificial Heart Lung Machines Industry Drivers
  3. 9.3 Artificial Heart Lung Machines Industry Opportunities and Challenges
  4. 9.4 Artificial Heart Lung Machines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst